On Nov 10, GTX Inc. (NASDAQ:GTXI) reported financial results for the third quarter ended September 30, 2014. As of September 30, 2014, cash and short-term investments were $11.5 million compared to $14.7 million at December 31, 2013. Reported third quarter cash and short-term investments does not include the approximately $42.8 million in net proceeds the Company will receive upon closing of the private placement announced. GTX Inc. (NASDAQ:GTXI) belongs to Healthcare sector. Its weekly performance is 0.19%. On last trading day company shares ended up $0.54. GTX Inc. (NASDAQ:GTXI) distance from 50-day simple moving average (SMA50) is -19.28%. On Nov. 4, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported financial results for the three and nine months ended September 30, 2014, outlined upcoming milestones in its development programs for chronic hepatitis C viral infection (HCV), and introduced a novel platform for advancing oral complement factor D inhibitors. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares decreased -9.16% in last trading session and ended the day at $13.49. ACHN return on assets is -42.30%. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) quarterly performance is 45.84%. PCTEL, Inc. (NASDAQ:PCTI), announced that the PCTEL Board of Directors has approved a 25 percent increase in the company's regular quarterly dividend to $.05 per share on its common stock. The quarterly dividend had been $.04 per share. On 13 November, PCTEL, Inc. (NASDAQ:PCTI) shares advanced 3.92% and was closed at $8.22. PCTI EPS growth in last 5 year was 24.60%. PCTEL, Inc. (NASDAQ:PCTI) year to date (YTD) performance is -12.37%. ERBA Diagnostics, Inc. (NYSEMKT:ERB) on Nov 10, reported profit of $128,000, or roughly breakeven on a per-share basis, in its third quarter. The company, based in Miami, posted revenue of $6.5 million in the period. ERBA Diagnostics, Inc. (NYSEMKT:ERB) ended the last trading day at $3.04. Company weekly volatility is calculated as 9.32% and price to cash ratio as 49.41. ERBA Diagnostics, Inc. (NYSEMKT:ERB) showed a weekly performance of -1.94%. Northern Oil & Gas (NYSE:NOG) was upgraded by investment analysts at Raymond James from an “underperform” rating to a “market perform” rating in a note issued to investors on Friday, TheFlyOnTheWall.com reports. Northern Oil and Gas, Inc. (NYSEMKT:NOG) shares decreased -0.52% in last trading session and ended the day at $11.58. NOG Gross Margin is 88.40% and its return on assets is 4.70%. Northern Oil and Gas, Inc. (NYSEMKT:NOG) quarterly performance is -27.58%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
